The Global Saline Laxative Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/investment opportunities.
Based on prescription type the market is segmented into over-the-counter saline laxatives and prescribed saline laxatives. Based on product type the market is segmented into milk of magnesia, sodium phosphate mono basic, fleet phospho-soda, magnesium hydroxide, Di basic sodium phosphate and magnesium citrate. Magnesium hydroxide further divided into sodium phosphates.
Based on distribution channel the market is divided into drug store, pharmacies, hospital pharmacies and online.
This industry report analyzes the global markets for Saline Laxative across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
The Saline Laxative Market report provides data tables, includes charts and graphs for visual analysis.
Regional Analysis: North America - US - Canada - Mexico
Europe - France - Germany - Italy - Spain - UK - Rest of Europe
Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia
Middle East - Saudi Arabia - UAE - Rest of Middle East
Latin America - Argentina - Brazil - Rest of Latin America
Rest of the World -Africa -Caribbean
Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments
Our reports have been used by over 10K customers, including:
122 pages •
By Infiniti Research Limited
• May 2018
About Digestive Remedies Digestive remedies are used for the treatment of gastrointestinal (GI) disorders. The most common digestive disorders are indigestion, heartburn, diarrhoea, irritable bowel syndrome (IBS), motion sickness, paediatric digestive disorders, and constipation. Technavio’s analysts forecast the...
Irritable bowel syndrome (IBS) is a chronic gastrointestinal and functional bowel disorder that affects around 10-15% of population during their lifetime. It causes abdominal pain, cramps, bloating, diarrhea or constipation. The drug market for the disease is estimated to be around $1.5 billion. Over 50 companies and universities are...
With an estimated $600 million market value, the Opioid Induced Constipation (OIC) is one of the most common gastrointestinal conditions, presenting robust opportunities for development of treatment options. The condition is observed in patients who undergo opioid therapy and is characterized by lowered number of bowel movements and tough...
With an estimated 25 million people being affected by Gastroesophageal reflux disease (GERD) in the US, it is considered as one of the most common GI Disorders. GERD causes stomach contents regurgitate into the esophagus, causing damage to esophagus. Around 30 companies and universities are focusing on developing treatment options for...
With an estimated 1.5 million to 2 million people being affected worldwide, Diarrhea is the most catastrophic disease causing morbidity among children. Developing and poor countries are most susceptible to diarrhea. Over 60 companies and universities are focusing on developing treatment options for Diarrhea. To assist investigators...
Traveler’s Diarrhea is a common gastrointestinal disease with loose stools and abdominal cramps. It is mostly caused by E. coli bacteria. Africans and South Asian population is mostly susceptible to the disease. Around 10 companies and universities are focusing on developing treatment options for Traveler’s Diarrhea. To assist...